Form 4: Eliem Therapeutics EVP Valerie Morisset Sells Shares in Multiple Transactions

Valerie Morisset, EVP, R&D and CSO of Eliem Therapeutics, Inc., sold a total of 105,931 shares of common stock between July 9 and July 11, 2024.

Summary

• Valerie Morisset, an executive at Eliem Therapeutics, Inc. (ELYM), reported the sale of company stock.
• The sales occurred over three days, from July 9 to July 11, 2024.
• On July 9, 2024, 5,931 shares were sold at a price of $6.66 per share.
• On July 10, 2024, 50,000 shares were sold at $6.83 per share.
• On July 11, 2024, another 50,000 shares were sold at $7.11 per share.
• Following these transactions, Morisset directly owns 344,683 shares of Eliem Therapeutics common stock.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. It's a Form 4 filing indicating an insider stock sale, which can sometimes be perceived negatively by investors, although it's a routine event.

Industry Context

Insider sales are a common occurrence, but investors often monitor them closely for signals about a company's prospects. Large or frequent sales by executives can sometimes raise concerns, while occasional sales are often attributed to personal financial planning.

Stakeholder Impact

• Shareholders may react to the news of the stock sale, potentially impacting the stock price in the short term.

Key Dates